Allarity Therapeutics Inc (NASDAQ:ALLR) — Market Cap & Net Worth
Market Cap & Net Worth: Allarity Therapeutics Inc (ALLR)
Allarity Therapeutics Inc (NASDAQ:ALLR) has a market capitalization of $20.72 Million ($20.72 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #25025 globally and #5260 in its home market, demonstrating a -16.77% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Allarity Therapeutics Inc's stock price $1.34 by its total outstanding shares 15460724 (15.46 Million). Review ALLR liabilities breakdown to assess the company's total debt and financial obligations.
Allarity Therapeutics Inc Market Cap History: 2021 to 2026
Allarity Therapeutics Inc's market capitalization history from 2021 to 2026. Data shows change from $15.46 Trillion to $20.72 Million (-95.08% CAGR).
Index Memberships
Allarity Therapeutics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.00% | #718 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #2355 of 3165 |
Weight: Allarity Therapeutics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Allarity Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Allarity Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
52.18x
Allarity Therapeutics Inc's market cap is 52.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $16.70 Million | $320.00K | -$11.23 Million | 52.18x | N/A |
Competitor Companies of ALLR by Market Capitalization
Companies near Allarity Therapeutics Inc in the global market cap rankings as of June 18, 2026.
Key companies related to Allarity Therapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #444 globally with a market cap of $62.63 Billion USD.
- UCB SA (BR:UCB): Ranked #549 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $458.99 |
| #444 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.63 Billion | $607.93 |
| #549 | UCB SA | BR:UCB | $49.68 Billion | €252.40 |
| #573 | Argen-X | BR:ARGX | $47.14 Billion | €780.20 |
Allarity Therapeutics Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Allarity Therapeutics Inc's market cap moved from $15.46 Trillion to $ 20.72 Million, with a yearly change of -95.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $20.72 Million | +24.07% |
| 2025 | $16.70 Million | -7.69% |
| 2024 | $18.09 Million | -99.65% |
| 2023 | $5.11 Billion | -99.87% |
| 2022 | $3.82 Trillion | -75.32% |
| 2021 | $15.46 Trillion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Allarity Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.72 Million USD |
| MoneyControl | $20.72 Million USD |
| MarketWatch | $20.72 Million USD |
| marketcap.company | $20.72 Million USD |
| Reuters | $20.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Allarity Therapeutics Inc
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead d… Read more